BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10970976)

  • 21. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J; Qureshi AR; Divino-Filho JC; Bárány P; Heimbürger O; Lindholm B; Stenvinkel P
    Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.
    Ong K; Kratzsch J; Kiess W; Costello M; Scott C; Dunger D
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4266-9. PubMed ID: 11095465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.
    Tönshoff B; Blum WF; Wingen AM; Mehls O
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2684-91. PubMed ID: 7545697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships of serum levels of insulinlike growth factors with indices of bone metabolism and nutritional conditions in hemodialysis patients.
    Nanba K; Nagake Y; Miyatake N; Nakao K; Akagi S; Sugimoto T; Yamasaki H; Oishi K; Ichikawa H; Makino H
    Nephron; 2001 Oct; 89(2):145-52. PubMed ID: 11549896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary predictors of the insulin-like growth factor system in adolescent females: results from the Dietary Intervention Study in Children (DISC).
    Kerver JM; Gardiner JC; Dorgan JF; Rosen CJ; Velie EM
    Am J Clin Nutr; 2010 Mar; 91(3):643-50. PubMed ID: 20089725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis.
    Pucilowska JB; Davenport ML; Kabir I; Clemmons DR; Thissen JP; Butler T; Underwood LE
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1516-21. PubMed ID: 7505287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus.
    Gannon MC; Nuttall FQ
    Metabolism; 2011 Sep; 60(9):1300-11. PubMed ID: 21406307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of protein intake on plasma and erythrocyte free amino acids and serum IGF-I and IGFBP-1 levels in rats.
    Filho JC; Hazel SJ; Anderstam B; Bergström J; Lewitt M; Hall K
    Am J Physiol; 1999 Oct; 277(4):E693-701. PubMed ID: 10516129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.
    Thierry van Dessel HJ; Chandrasekher Y; Yap OW; Lee PD; Hintz RL; Faessen GH; Braat DD; Fauser BC; Giudice LC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes.
    Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4301-9. PubMed ID: 8954031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone treatment in hemodialysis patients--a randomized, double-blind, placebo-controlled study.
    Ericsson F; Filho JC; Lindgren BF
    Scand J Urol Nephrol; 2004; 38(4):340-7. PubMed ID: 15669595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.